Franklin Resources’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $53.6M | Buy |
936,044
+2,165
| +0.2% | +$119K | 0.01% | 651 |
|
|
2026
Q1 | $52.8M | Buy |
933,879
+838,778
| +882% | +$48.9M | 0.01% | 634 |
|
|
2025
Q4 | $5.65M | Sell |
95,101
-11,838
| -11% | -$644K | ﹤0.01% | 1351 |
|
|
2025
Q3 | $5.79M | Sell |
106,939
-303,853
| -74% | -$17.4M | ﹤0.01% | 1369 |
|
|
2025
Q2 | $22.6M | Buy |
410,792
+46,718
| +13% | +$2.75M | 0.01% | 889 |
|
|
2025
Q1 | $25.7M | Sell |
364,074
-85,687
| -19% | -$5.76M | 0.01% | 827 |
|
|
2024
Q4 | $29.6M | Sell |
449,761
-35,614
| -7% | -$2.39M | 0.01% | 791 |
|
|
2024
Q3 | $34.1M | Buy |
485,375
+91,463
| +23% | +$7.65M | 0.01% | 718 |
|
|
2024
Q2 | $32.4M | Buy |
393,912
+75,864
| +24% | +$6.32M | 0.01% | 696 |
|
|
2024
Q1 | $27.8M | Buy |
318,048
+16,284
| +5% | +$1.46M | 0.01% | 762 |
|
|
2023
Q4 | $29.1M | Sell |
301,764
-264,478
| -47% | -$23.4M | 0.01% | 659 |
|
|
2023
Q3 | $50.1M | Sell |
566,242
-269,989
| -32% | -$24M | 0.03% | 491 |
|
|
2023
Q2 | $72.5M | Buy |
836,231
+150,936
| +22% | +$14.2M | 0.03% | 431 |
|
|
2023
Q1 | $66.6M | Buy |
685,295
+353,163
| +106% | +$36.6M | 0.03% | 457 |
|
|
2022
Q4 | $34.4M | Sell |
332,132
-113,594
| -25% | -$10.7M | 0.02% | 630 |
|
|
2022
Q3 | $37.8M | Buy |
445,726
+2,536
| +0.6% | +$226K | 0.02% | 608 |
|
|
2022
Q2 | $36.7M | Buy |
443,190
+1,286
| +0.3% | +$102K | 0.02% | 634 |
|
|
2022
Q1 | $34.1M | Sell |
441,904
-85,347
| -16% | -$7.14M | 0.01% | 710 |
|
|
2021
Q4 | $46.6M | Buy |
527,251
+43,525
| +9% | +$3.59M | 0.02% | 656 |
|
|
2021
Q3 | $37.4M | Buy |
483,726
+11,839
| +3% | +$934K | 0.01% | 739 |
|
|
2021
Q2 | $39.4M | Buy |
471,887
+41,661
| +10% | +$3.3M | 0.02% | 712 |
|
|
2021
Q1 | $32.5M | Sell |
430,226
-714
| -0.2% | -$58.3K | 0.01% | 734 |
|
|
2020
Q4 | $37.8M | Buy |
430,940
+25,451
| +6% | +$2.02M | 0.02% | 667 |
|
|
2020
Q3 | $30.8M | Buy |
405,489
+5,003
| +1% | +$506K | 0.01% | 668 |
|
|
2020
Q2 | $51.1M | Sell |
400,486
-1,791
| -0.4% | -$178K | 0.03% | 523 |
|
|
2020
Q1 | $34M | Sell |
402,277
-177,824
| -31% | -$15.3M | 0.02% | 554 |
|
|
2019
Q4 | $49M | Sell |
580,101
-652,766
| -53% | -$49.3M | 0.03% | 547 |
|
|
2019
Q3 | $83.1M | Sell |
1,232,867
-217,234
| -15% | -$16.7M | 0.05% | 409 |
|
|
2019
Q2 | $124M | Sell |
1,450,101
-2,567
| -0.2% | -$220K | 0.07% | 310 |
|
|
2019
Q1 | $129M | Buy |
1,452,668
+180,239
| +14% | +$16.7M | 0.07% | 302 |
|
|
2018
Q4 | $108M | Sell |
1,272,429
-31,577
| -2% | -$3M | 0.07% | 313 |
|
|
2018
Q3 | $126M | Sell |
1,304,006
-390,061
| -23% | -$38.9M | 0.06% | 321 |
|
|
2018
Q2 | $160M | Buy |
1,694,067
+323,051
| +24% | +$28.3M | 0.08% | 261 |
|
|
2018
Q1 | $111M | Sell |
1,371,016
-339,556
| -20% | -$29.1M | 0.06% | 337 |
|
|
2017
Q4 | $153M | Buy |
1,710,572
+80,568
| +5% | +$7.01M | 0.07% | 277 |
|
|
2017
Q3 | $152M | Sell |
1,630,004
-81,017
| -5% | -$7.16M | 0.07% | 277 |
|
|
2017
Q2 | $155M | Buy |
1,711,021
+88,964
| +5% | +$8.09M | 0.08% | 263 |
|
|
2017
Q1 | $142M | Buy |
1,622,057
+480
| +0% | +$42.7K | 0.07% | 279 |
|
|
2016
Q4 | $134M | Sell |
1,621,577
-25,319
| -2% | -$2.18M | 0.07% | 276 |
|
|
2016
Q3 | $152M | Buy |
1,646,896
+284,900
| +21% | +$26.8M | 0.08% | 259 |
|
|
2016
Q2 | $106M | Buy |
1,361,996
+1,106
| +0.1% | +$94K | 0.06% | 335 |
|
|
2016
Q1 | $112M | Sell |
1,360,890
-122,249
| -8% | -$9.95M | 0.06% | 319 |
|
|
2015
Q4 | $155M | Buy |
1,483,139
+73,450
| +5% | +$7.67M | 0.08% | 259 |
|
|
2015
Q3 | $148M | Sell |
1,409,689
-298,544
| -17% | -$39.9M | 0.07% | 274 |
|
|
2015
Q2 | $234M | Buy |
1,708,233
+185,068
| +12% | +$22.9M | 0.11% | 214 |
|
|
2015
Q1 | $190M | Sell |
1,523,165
-60,600
| -4% | -$6.42M | 0.09% | 249 |
|
|
2014
Q4 | $143M | Sell |
1,583,765
-65,900
| -4% | -$5.48M | 0.06% | 289 |
|
|
2014
Q3 | $119M | Sell |
1,649,665
-175,500
| -10% | -$11.5M | 0.05% | 323 |
|
|
2014
Q2 | $114M | Buy |
1,825,165
+111,000
| +6% | +$6.71M | 0.05% | 353 |
|
|
2014
Q1 | $117M | Buy |
1,714,165
+375,900
| +28% | +$27.7M | 0.06% | 337 |
|
|
2013
Q4 | $94M | Sell |
1,338,265
-148,000
| -10% | -$10.1M | 0.05% | 381 |
|
|
2013
Q3 | $107M | Buy |
1,486,265
+528,100
| +55% | +$35.1M | 0.06% | 334 |
|
|
2013
Q2 | $53.5M | Buy |
+958,165
| New | +$59.7M | 0.03% | 493 |
|
Other funds holding BMRN
VPC
Franklin Resources's BMRN Position: Q2 2026 in Review
Franklin Resources increased its BioMarin Pharmaceuticals (BMRN) stake by 0.23% in Q2 2026, buying an estimated $119K and bringing the position to 936,044 shares worth $53.6M. The position accounts for 0.01% of the portfolio, ranked #651.
Franklin Resources first reported a position in BMRN in Q2 2013 and has held it in 53 quarters since. The position peaked at $234M in Q2 2015. 561 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.
- Franklin Resources held 936,044 shares of BioMarin Pharmaceuticals worth $53.6M as of Q2 2026.
- Franklin Resources bought 2,165 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $119K.
- BioMarin Pharmaceuticals made up 0.01% of Franklin Resources's portfolio in Q2 2026, its #651 holding.
- Franklin Resources first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Franklin Resources's BioMarin Pharmaceuticals position peaked at $234M in Q2 2015.
- 561 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.
Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.